A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Non-metastatic Breast Cancer
Interventions: DRUG: HSP-130
Sponsor: Pfizer
Collaborators: Hospira, now a wholly owned subsidiary of Pfizer